Yuichi Ando
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Glioma Diagnosis and Treatment
Papers in
- Oncology 25
- Cancer Immunotherapy and Biomarkers 19
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Osamu Maeda (18 shared papers)Shunji Takahashi (3 shared papers)Hironobu Minami (6 shared papers)Satoshi Nishiwaki (1 shared paper)Kazuki Nishida (7 shared papers)Tomoyuki Kakizume (1 shared paper)Naoko Suenaga (1 shared paper)Cornelia Quadt (1 shared paper)
- Journals
- Cancer Science (6 papers)International Journal of Clinical Oncology (2 papers)Clinical Cancer Research (2 papers)Annals of Oncology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Yuichi Ando
50 papers receiving 470 citations
Peers
Comparison fields: 5 of 55
- Oncology 158
- Genetics 53
- Drug Discovery 1
- Pulmonary and Respiratory Medicine 62
- Cancer Research 27
Countries citing papers authored by Yuichi Ando
This map shows the geographic impact of Yuichi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Ando more than expected).
Fields of papers citing papers by Yuichi Ando
This network shows the impact of papers produced by Yuichi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Ando. The network helps show where Yuichi Ando may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuichi Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 58 | |
| 2 | 2018 | 45 | |
| 3 | 2022 | 44 | |
| 4 | 2011 | 40 | |
| 5 | 2021 | 34 | |
| 6 | 2021 | 23 | |
| 7 | 2021 | 21 | |
| 8 | 2020 | 20 | |
| 9 | 2021 | 18 | |
| 10 | 2020 | 17 | |
| 11 | 2020 | 14 | |
| 12 | 2022 | 11 | |
| 13 | 2020 | 10 | |
| 14 | 2024 | 10 | |
| 15 | 2019 | 7 | |
| 16 | 2018 | 6 | |
| 17 | 2020 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2022 | 5 |
About Yuichi Ando
Yuichi Ando is a scholar working on Oncology, Pharmacology, Pulmonary and Respiratory Medicine, Surgery and Geriatrics and Gerontology, having authored 59 papers that have together received 481 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Pharmacogenetics and Drug Metabolism (5 papers), Esophageal Cancer Research and Treatment (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Frailty in Older Adults (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Oncology (158 citations), Genetics (53 citations), Drug Discovery (1 citation), Pulmonary and Respiratory Medicine (62 citations) and Cancer Research (27 citations). Yuichi Ando has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Osamu Maeda, Shunji Takahashi, Hironobu Minami, Satoshi Nishiwaki, Kazuki Nishida, Tomoyuki Kakizume, Naoko Suenaga, Cornelia Quadt, Yasuhide Yamada and Ayako Mitsuma. Their work appears in journals such as Cancer Science, International Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.